Neurological Damage by Coronaviruses: A Catastrophe in the Queue!
Frontiers in Immunology, ISSN: 1664-3224, Vol: 11, Page: 565521
2020
- 39Citations
- 165Captures
- 3Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations39
- Citation Indexes39
- 39
- CrossRef4
- Captures165
- Readers165
- 165
- Mentions3
- Blog Mentions1
- Blog1
- News Mentions1
- News1
- References1
- Wikipedia1
Most Recent Blog
The Problem of 'Long Haul' COVID
More and more patients are dealing with major symptoms that linger for months -- Read more on ScientificAmerican.com
Most Recent News
Neurological Damage by Coronaviruses: A Catastrophe in the Queue!
Front Immunol. 2020;11:565521. Epub 2020 Sep 10 Authors: Mishra R, Banerjea AC PubMed: 33013930 Submit Comment
Review Description
Neurological disorders caused by neuroviral infections are an obvious pathogenic manifestation. However, non-neurotropic viruses or peripheral viral infections pose a considerable challenge as their neuropathological manifestations do not emerge because of primary infection. Their secondary or bystander pathologies develop much later, like a syndrome, during and after the recovery of patients from the primary disease. Massive inflammation caused by peripheral viral infections can trigger multiple neurological anomalies. These neurological damages may range from a general cognitive and motor dysfunction up to a wide spectrum of CNS anomalies, such as Acute Necrotizing Hemorrhagic Encephalopathy, Guillain-Barré syndrome, Encephalitis, Meningitis, anxiety, and other audio-visual disabilities. Peripheral viruses like Measles virus, Enteroviruses, Influenza viruses (HIN1 series), SARS-CoV-1, MERS-CoV, and, recently, SARS-CoV-2 are reported to cause various neurological manifestations in patients and are proven to be neuropathogenic even in cellular and animal model systems. This review presents a comprehensive picture of CNS susceptibilities toward these peripheral viral infections and explains some common underlying themes of their neuropathology in the human brain.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85091486883&origin=inward; http://dx.doi.org/10.3389/fimmu.2020.565521; http://www.ncbi.nlm.nih.gov/pubmed/33013930; https://www.frontiersin.org/article/10.3389/fimmu.2020.565521/full; https://dx.doi.org/10.3389/fimmu.2020.565521; https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.565521/full
Frontiers Media SA
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know